| Literature DB >> 30971601 |
Akhil Gurram1, Neethu Krishna1, Anu Vasudevan2, Luis Alberto Baquero3, Aveek Jayant4, Praveen Kerala Varma1.
Abstract
Background: The female gender is considered as a risk factor for morbidity and mortality after coronary artery bypass grafting (CABG). Aim: In this analysis, we assessed the impact of female gender on early outcome after CABG. Study Design: This is a retrospective analysis of data from our center situated in South India. Statistical Analysis: Patients were categorized according to gender and potential differences in pre-operative and post-operative factors were explored. Significant risk factors were then built in a multivariate model to account for differences in predicting gender influence on surgical outcome.Entities:
Keywords: 30-day mortality; coronary artery bypass grafting; gender; outcome; risk stratification
Mesh:
Year: 2019 PMID: 30971601 PMCID: PMC6489402 DOI: 10.4103/aca.ACA_27_18
Source DB: PubMed Journal: Ann Card Anaesth ISSN: 0971-9784
Variables included in the study
| Preoperative characteristics |
| Age |
| Gender |
| Emergency/elective/urgent |
| EuroSCORE II |
| DM |
| HTN |
| DLP |
| Hypothyroidism |
| Recent MI |
| Renal disease |
| COPD |
| PVD |
| Carotid stenosis |
| Stroke |
| Preoperative sinus rhythm |
| LV function |
| Intraoperative outcome variables |
| Mean grafts |
| LIMA graft usage |
| Postoperative outcome variables |
| Ventilation hours |
| Usage of inotropes |
| Re-exploration |
| IABP usage |
| Atrial fibrillation |
| ICU stay |
| Hospital stay |
| Stroke |
| Renal dysfunction |
| Mediastinitis |
| SSIs |
| BSIs |
| Usage of therapeutic antibiotics |
| Hospital readmissions |
MI: Myocardial infarction, COPD: Chronic obstructive pulmonary disease, PVD: Peripheral vascular disease, IABP: Intra-aortic balloon pump, ICU: Intensive Care Unit, BSIs: Blood stream infection, SSIs: Surgical site infection, DLP: Dyslipidemia, HTN: Hypertension, DM: Diabetes mellitus, LV: Left ventricular, LIMA: Left internal mammary artery
Preoperative, intraoperative and postoperative variables and their distribution with gender
| Variables | Gender | ||
|---|---|---|---|
| Female ( | Male ( | ||
| Urgent cases | 9 (6.8) | 31 (4.8) | 0.349 |
| DM | 103 (78.03) | 431 (67.24) | 0.015* |
| HTN | 96 (72.72) | 450 (70.2) | 0.539 |
| DLP | 68 (51.51) | 244 (38.07) | 0.004* |
| Hypothyroidism | 16 (12.21) | 19 (2.96) | <0.001** |
| COPD | 11 (8.4) | 52 (8.11) | 0.933 |
| PVOD | 4 (3.05) | 33 (5.14) | 0.299 |
| Carotid stenosis | 2 (1.53) | 19 (2.96) | 0.351 |
| Preoperative stroke | 1 (0.76) | 14 (2.18) | 0.279 |
| Preoperative renal dysfunction | 6 (4.58) | 51 (7.96) | 0.172 |
| Recent MI | 51 (38.64) | 204 (31.82) | 0.13 |
| Preoperative sinus rhythm | 132 (100) | 637 (99.37) | 0.363 |
| LIMA graft used | 128 (96.97) | 628 (97.97) | 0.475 |
| Mortality | 4 (3.03) | 20 (3.12) | 0.957 |
| Re-exploration | 0 | 18 (2.81) | 0.051* |
| Renal failure requiring dialysis | 2 (1.53) | 8 (1.25) | 0.805 |
| Ventilator associated pneumonia | 0 | 0 | - |
| Mediastinitis | 7 (5.34) | 9 (1.40) | 0.004* |
| SSIs | 30 (22.73) | 75 (11.70) | 0.001* |
| PoAF | 22 (16.80) | 114 (17.78) | 0.759 |
| Postoperative stroke | 1 (0.76) | 8 (1.25) | 0.632 |
| Usage of IABP | 2 (1.53) | 16 (2.50) | 0.88 |
| BSIs | 5 (3.82) | 21 (3.28) | 0.766 |
| Therapeutic antibiotics used | 32 (24.43) | 58 (9.05) | <0.001** |
| Readmissions | 28 (21.37) | 65 (10.14) | <0.001** |
| Usage of inotropes >24 h | 53 (39.70) | 262 (40.87) | 0.633 |
*Significant P<0.05, **P<0.001. MI: Myocardial infarction, COPD: Chronic obstructive pulmonary disease, IABP: Intra-aortic balloon pump, PVOD: Peripheral vascular occlusive disease, LIMA: Left internal mammary artery, PoAF: Postoperative atrial fibrillation, BSIs: Blood stream infection, SSIs: Surgical site infection, DLP: Dyslipidemia, HTN: Hypertension, DM: Diabetes mellitus
Mean and standard deviation of preoperative, intraoperative, and postoperative continuous variables with gender
| Variables | Gender | Mean±SD | ||
|---|---|---|---|---|
| Age | Female | 132 | 61.7±8.26 | 0.901 |
| Male | 641 | 61.6±8.75 | ||
| HbA1c | Female | 101 | 7.84±1.88 | 0.32 |
| Male | 378 | 7.47±1.88 | ||
| LV function | Female | 132 | 1.5±0.84 | 0.32 |
| Male | 641 | 1.59±0.9 | ||
| EF | Female | 132 | 56.45±6.94 | 0.38 |
| Male | 641 | 54.83±8.61 | ||
| EuroSCORE II | Female | 132 | 2.8±3.82 | 0.78 |
| Male | 527 | 2.65±5.57 | ||
| Mean grafts/patients | Female | 132 | 3.48±0.77 | 0.139 |
| Male | 641 | 3.59±0.84 | ||
| Length of ICU stay (days) | Female | 131 | 3.49±2.31 | 0.407 |
| Male | 640 | 3.75±3.49 | ||
| Length of hospital stay (days) | Female | 130 | 11.63±6.5 | 0.693 |
| Male | 634 | 11.89±6.91 | ||
| Usage of inotropes (days) | Female | 104 | 1.4±1.71 | 0.51 |
| Male | 508 | 1.56±2.23 | ||
| Ventilator hours | Female | 132 | 15.44±24.02 | 0.758 |
| Male | 640 | 16.51±38.38 |
*Significant P<0.05. LV function was denoted by a scoring system: 1-normal (EF >60%); 2-mild dysfunction (EF 50%-60%); 3-moderate dysfunction (EF 35%-50%), and 4 for severe dysfunction (EF <35%). LV: Left ventricular, ICU: Intensive Care Unit, SD: Standard deviation, HbA1c: Hemoglobin A1c, EF: Ejection fraction
Association of preoperative and postoperative variables with mortality
| Variables | Category | Mortality | ||
|---|---|---|---|---|
| Yes 24 (%), | No 749 (%), | |||
| Gender | Female | 4 (3) | 128 (97) | 0.957 |
| Male | 20 (3.1) | 621 (96.9) | ||
| Urgency of surgery | Elective | 17 (2.3) | 716 (97.7) | <0.001** |
| Emergency | 7 (17.5) | 33 (82.5) | ||
| DM | Yes | 17 (3.2) | 517 (96.8) | 0.85 |
| No | 7 (3) | 232 (97) | ||
| HTN | Yes | 21 (3.9) | 524 (96.1) | 0.064 |
| No | 3 (1.3) | 225 (98.7) | ||
| DLP | Yes | 15 (4.8) | 297 (95.2) | 0.025* |
| No | 9 (2) | 452 (98) | ||
| Hypothyroidism | Yes | 0 | 35 (100) | 0.278 |
| No | 24 (3.3) | 714 (96.7) | ||
| Recent MI | Yes | 12 (4.7) | 243 (95.3) | 0.072 |
| No | 12 (2.3) | 506 (97.7) | ||
| Preoperative renal dysfunction | Yes | 7 (12.3) | 50 (87.7) | <0.001** |
| No | 17 (2.4) | 699 (97.6) | ||
| COPD | Yes | 6 (9.5) | 57 (90.5) | 0.002* |
| No | 18 (2.5) | 692 (97.5) | ||
| PVD | Yes | 2 (5.4) | 35 (94.6) | 0.408 |
| No | 22 (3) | 714 (97) | ||
| Carotid stenosis | Yes | 1 (4.8) | 20 (95.2) | 0.657 |
| No | 23 (3.1) | 729 (96.9) | ||
| Preoperative stroke | Yes | 23 (62.2) | 14 (37.8) | 0.422 |
| No | 23 (3) | 735 (97) | ||
| HbA1c | Yes | 7 (1.9) | 366 (98.1) | 0.25 |
| No | 4 (3.8) | 102 (96.2) | ||
| Preoperative sinus rhythm | Yes | 24 (3.1) | 745 (96.9) | 0.72 |
| No | 0 | 4 (100) | ||
| Inotropic usage | Yes | 17 (5.4) | 296 (94.6) | 0.002* |
| No | 7 (1.5) | 453 (98.5) | ||
| Re-exploration | Yes | 4 (22.2) | 14 (77.8) | <0.001** |
| No | 20 (2.6) | 735 (97.4) | ||
| IABP usage | Yes | 6 (31.6) | 13 (68.4) | <0.001** |
| No | 18 (2.4) | 736 (97.6) | ||
| PoAF | Yes | 11 (8.1) | 125 (91.9) | <0.001** |
| No | 13 (2) | 624 (98) | ||
| Postoperative stroke | Yes | 1 (11.1) | 8 (88.9) | 0.164 |
| No | 23 (3) | 741 (97) | ||
| Postoperative renal failure requiring dialysis | Yes | 5 (50) | 5 (50) | <0.001** |
| No | 19 (2.5) | 744 (97.5) | ||
| Mediastinitis | Yes | 1 (6.2) | 15 (93.8) | 0.464 |
| No | 23 (3.1) | 734 (96.9) | ||
| SSI | Yes | 2 (1.9) | 103 (98.1) | 0.446 |
| No | 22 (3.3) | 646 (96.7) | ||
| BSI | Yes | 4 (15.4) | 22 (84.6) | <0.001** |
| No | 20 (2.7) | 727 (97.3) | ||
| Therapeutic antibiotics | Yes | 11 (12.2) | 79 (87.8) | <0.001** |
| No | 13 (1.9) | 670 (98.1) | ||
| Readmissions | Yes | 3 (3.2) | 91 (96.8) | 0.959 |
| No | 21 (3.1) | 658 (96.9) | ||
*Significant P<0.05, **P<0.001. DM: Diabetes mellitus, HTN: Hypertension, DLP: Dyslipidemia, MI: Myocardial infarction, COPD: Chronic obstructive pulmonary disease, PVD: Peripheral vascular disease, IABP: Intra-aortic balloon pump, HbA1c: Hemoglobin A1c, PoAF: Postoperative atrial fibrillation, SSI: Surgical site infection, BSI: Blood stream infection
Association of continuous variables with mortality
| Variables | Mortality (mean±SD) | ||
|---|---|---|---|
| Yes | No | ||
| Age | 66.25±8.65 | 61.47±8.62 | 0.008* |
| EuroSCORE II | 6.87±7.36 | 2.56±5.14 | <0.001** |
| HbA1c | 7.16±1.9 | 7.56±1.89 | 0.492 |
| Length of ICU stay | 7±8.83 | 3.6±2.94 | <0.001** |
| Length of hospital stay | 14.71±14.04 | 11.75±6.47 | 0.037* |
*Significant P<0.05, **P<0.001. SD: Standard deviation, HbA1c: Hemoglobin A1c, ICU: Intensive Care Unit
Figure 1Multivariate analysis of categorical and continuous variables with mortality. Odds ratio with confidence interval is represented in Forest plot diagram